申请人:Han Bo
公开号:US20080306089A1
公开(公告)日:2008-12-11
The present invention relates to a compound of formula I
wherein
R
1
, R
2
, R
3
, and n are as defined herein or to a pharmaceutically acceptable acid addition salt thereof. These compounds are NK3 receptor antagonists, useful for the treatment of such disorders as depression, pain, bipolar disorders, psychosis, Parkinson's disease, schizophrenia, anxiety, and attention deficit hyperactivity disorder (ADHD).
本发明涉及一种化合物,其化学式为I,其中R1,R2,R3和n的定义如下,或其药用可接受的酸加盐。这些化合物是NK3受体拮抗剂,可用于治疗抑郁症、疼痛、双相情感障碍、精神病、帕金森病、精神分裂症、焦虑症和注意力缺陷多动障碍(ADHD)等疾病。